Pain
Conference Coverage
Warn patients about illicit drugs doctored with fentanyl
Most patients with drug use disorders are testing positive for fentanyl at his center, said Dr. Edwin A. Salsitz, of Mount Sinai Beth Israel.
News
Good news, bad news for buprenorphine in opioid use disorder
The findings “underscore the need to pursue actions that expand access to buprenorphine-based OUD treatment,” said Dr. Beth Han and associates.
Latest News
FDA approves combo pill for severe, acute pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
News
Tramadol linked to higher risk of mortality, compared with codeine
Tramadol is widely used for noncancer pain but, as compared with codeine, it was associated with a higher risk for adverse outcomes, including...
News
FDA OKs new high-dose naloxone product for opioid overdose
“The higher intramuscular doses of naloxone in ZIMHI should result in more rapid and higher levels of naloxone in the systemic circulation.”
News
New antimigraine drugs linked with less risk for adverse events
The safety and efficacy of new antimigraine treatments were compared with current standard therapy, in a new systematic review.
News
Retraining the brain may eliminate chronic back pain
The effects of pain-reprocessing therapy on pain were mediated by lessening the belief that pain indicates tissue damage, the researchers said.
Program Profile
A Facility-Wide Plan to Increase Access to Medication for Opioid Use Disorder in Primary Care and General Mental Health Settings
Use of medication to treat opioid use disorder expanded after an interdisciplinary team engaged leadership, provided education, incentivized...
News
Opioid prescribing mapped: Alabama highest, New York lowest
The Medicare Part D opioid prescribing rate dropped in all 50 states from 2014 to 2019, but disparities remain.
News
Opioid prescriptions following Mohs surgery dropped over the last decade
The four opioids obtained most during the study period were hydrocodone (55%), codeine (16.3%), oxycodone (12%), and tramadol (11.6%).